Copyright (c) 2010 Yahoo! Inc. All rights reserved. http://news.yahoo.com/business/industries/pharmaceutical business Business - Pharmaceutical en-us Tue, 09 Feb 2010 23:12:05 GMT 5 142 18 http://news.yahoo.com/business/industries/pharmaceutical http://l.yimg.com/a/i/us/nws/th/main_142c.gif http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20100209/ap_on_bi_ge/us_earns_ims_health ap/20100209/us_earns_ims_health AP business Tue, 09 Feb 2010 23:12:05 GMT AP - IMS Health Inc., which provides market data to pharmaceutical and health care companies, said Tuesday its fourth-quarter profit shrank 27 percent as rising expenses and restructuring charges failed to offset higher revenue. http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20100209/ap_on_bi_ge/in_cvs_pharmacists__licenses ap/20100209/in_cvs_pharmacists__licenses AP business Tue, 09 Feb 2010 22:25:11 GMT AP - Pharmacy giant CVS will pay $1.95 million and verify that all of its pharmacists are licensed in Indiana to settle a state complaint that pharmacists with expired licenses dispensed prescriptions for several years at two of its drugstores, the state attorney general's office said Tuesday. http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20100209/ap_on_bi_ge/us_earns_ligand_pharma ap/20100209/us_earns_ligand_pharma AP business Tue, 09 Feb 2010 18:11:44 GMT AP - Ligand Pharmaceuticals Inc. said Tuesday it turned a profit in the fourth quarter, compared with a year ago when it booked a hefty acquisition-related charge. http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/afp/20100209/ts_alt_afp/entertainmentusmusicjackson afp/20100209/entertainmentusmusicjackson AFP us Tue, 09 Feb 2010 11:34:11 GMT <p><a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/afp/20100209/ts_alt_afp/entertainmentusmusicjackson"><img src="http://d.yimg.com/a/p/afp/20100209/capt.photo_1265714876972-11-0.jpg?x=86&y=130&q=85&sig=f4hrelOwm1bTEKMZBRIvhg--" align="left" height="130" width="86" alt="Michael Jackson's doctor Conrad Murray, seen here in the court, has pleaded not guilty to involuntary manslaughter at a court in Los Angeles in connection with the pop superstar's sudden death last year from a lethal cocktail of prescription drugs.(AFP/Mark Boster)" border="0" /></a>AFP - Michael Jackson's doctor has pleaded not guilty to involuntary manslaughter at a court in Los Angeles in connection with the pop superstar's sudden death last year from a lethal cocktail of prescription drugs.</p><br clear="all"/> <p><a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/afp/20100209/ts_alt_afp/entertainmentusmusicjackson"><img src="http://d.yimg.com/a/p/afp/20100209/capt.photo_1265714876972-11-0.jpg?x=86&y=130&q=85&sig=f4hrelOwm1bTEKMZBRIvhg--" align="left" height="130" width="86" alt="photo" title="Michael Jackson's doctor Conrad Murray, seen here in the court, has pleaded not guilty to involuntary manslaughter at a court in Los Angeles in connection with the pop superstar's sudden death last year from a lethal cocktail of prescription drugs.(AFP/Mark Boster)" border="0"/></a></p><br clear="all"/> (AFP) http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20100209/ap_on_bi_ge/us_crestor_expanded_approval ap/20100209/us_crestor_expanded_approval AP business Tue, 09 Feb 2010 00:02:16 GMT AP - Federal regulators have granted AstraZeneca approval to market its cholesterol pill Crestor as a preventive measure against heart attack and stroke in patients with healthy cholesterol levels. http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20100208/ap_on_bi_ge/us_earns_charles_river_laboratories ap/20100208/us_earns_charles_river_laboratories AP business Mon, 08 Feb 2010 22:53:38 GMT AP - Medical research equipment and services company Charles River Laboratories International Inc. reported a fourth-quarter on lower charges Monday, but revenue fell on weak demand from pharmaceutical and biotech companies. http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20100208/ap_on_bi_ge/us_eli_lilly_executive_compensation ap/20100208/us_eli_lilly_executive_compensation AP business Mon, 08 Feb 2010 21:50:43 GMT AP - Eli Lilly and Co. CEO John Lechleiter received a compensation package valued at $16.4 million for 2009, up 54 percent from 2008, the year he became the drug maker's chief executive, according to an Associated Press calculation of figures disclosed Monday in a regulatory filing. http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/nm/20100208/bs_nm/us_cvscaremark nm/20100208/us_cvscaremark Reuters business Mon, 08 Feb 2010 19:33:23 GMT <p><a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/nm/20100208/bs_nm/us_cvscaremark"><img src="http://d.yimg.com/a/p/rids/20100208/i/r1785292345.jpg?x=91&y=130&q=85&sig=pEayJzOX8DUILET8gILlhQ--" align="left" height="130" width="91" alt="A pedestrian walks past a CVS drugstore in Boston, Massachusetts November 1, 2006. REUTERS/Brian Snyder" border="0" /></a>Reuters - CVS Caremark Corp said recent problems at its pharmacy benefits management unit have been corrected and it posted a slightly better-than-expected rise in quarterly profit as its drugstore bested its rivals, driving the company's shares up as much as 8.8 percent.</p><br clear="all"/> <p><a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/nm/20100208/bs_nm/us_cvscaremark"><img src="http://d.yimg.com/a/p/rids/20100208/i/r1785292345.jpg?x=91&y=130&q=85&sig=pEayJzOX8DUILET8gILlhQ--" align="left" height="130" width="91" alt="photo" title="A pedestrian walks past a CVS drugstore in Boston, Massachusetts November 1, 2006. REUTERS/Brian Snyder" border="0"/></a></p><br clear="all"/> (Reuters) http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20100208/ap_on_bi_ge/us_earns_cvs_caremark ap/20100208/us_earns_cvs_caremark AP business Mon, 08 Feb 2010 17:29:42 GMT <p><a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20100208/ap_on_bi_ge/us_earns_cvs_caremark"><img src="http://d.yimg.com/a/p/ap/20100208/capt.b713da34a64c4f54afe67eda11c190e3.earns_cvs_caremark_nybz148.jpg?x=130&y=92&q=85&sig=JSocbcdM2cbpYZ4rje_RNA--" align="left" height="92" width="130" alt="FILE - In this Aug. 3, 2006 file photo, customers take advantage of the drive through pharmacy window outside a CVS drug store in a Bainbridge Twp., Ohio. CVS Caremark Corp. said Monday, Feb. 8, 2010, its profit rose 11 percent in the fourth quarter as results improved for its pharmacy benefits management business, which has lost billions in contracts for the new year.(AP Photo/Amy Sancetta, File)" border="0" /></a>AP - CVS Caremark Corp., one of the nation's biggest drugstore operators, said Monday its profit rose 11 percent in the fourth quarter as results improved for its pharmacy benefits management business.</p><br clear="all"/> <p><a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20100208/ap_on_bi_ge/us_earns_cvs_caremark"><img src="http://d.yimg.com/a/p/ap/20100208/capt.b713da34a64c4f54afe67eda11c190e3.earns_cvs_caremark_nybz148.jpg?x=130&y=92&q=85&sig=JSocbcdM2cbpYZ4rje_RNA--" align="left" height="92" width="130" alt="photo" title="FILE - In this Aug. 3, 2006 file photo, customers take advantage of the drive through pharmacy window outside a CVS drug store in a Bainbridge Twp., Ohio. CVS Caremark Corp. said Monday, Feb. 8, 2010, its profit rose 11 percent in the fourth quarter as results improved for its pharmacy benefits management business, which has lost billions in contracts for the new year.(AP Photo/Amy Sancetta, File)" border="0"/></a></p><br clear="all"/> (AP) http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20100205/ap_on_bi_ge/us_cvs_caremark_earnings_preview ap/20100205/us_cvs_caremark_earnings_preview AP business Fri, 05 Feb 2010 15:46:21 GMT AP - Drugstore operator and pharmacy benefits manager CVS Caremark Corp. reports its fourth-quarter results before the stock market opens Monday. http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20100205/ap_on_bi_ge/us_teva_pharma_settlements ap/20100205/us_teva_pharma_settlements AP business Fri, 05 Feb 2010 14:56:34 GMT AP - Teva Pharmaceutical Industries Ltd., the world's largest generic drugmaker, said Friday it is settling several lawsuits related to Medicaid reimbursement for its products, and is setting aside $315 million to cover the settlement and other suits. http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20100204/ap_on_bi_ge/us_eli_lilly_zyprexa_settlement ap/20100204/us_eli_lilly_zyprexa_settlement AP business Thu, 04 Feb 2010 19:35:58 GMT AP - Mississippi will receive $18.5 million from drug maker Eli Lilly and Co. as part of a settlement over claims the company promoted the anti-psychotic Zyprexa for ailments it was not federally approved to treat, Attorney General Jim Hood said Thursday. http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/afp/20100204/bs_afp/britainpharmacompanyearningsgsk afp/20100204/britainpharmacompanyearningsgsk AFP business Thu, 04 Feb 2010 14:44:28 GMT <p><a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/afp/20100204/bs_afp/britainpharmacompanyearningsgsk"><img src="http://d.yimg.com/a/p/afp/20100204/capt.photo_1264907862220-1-0.jpg?x=130&y=90&q=85&sig=UgDjgD1U9zLq8dsgulF_4Q--" align="left" height="90" width="130" alt="British pharmaceuticals giant GlaxoSmithKline on Thursday announced a 66-percent jump in fourth quarter net profit to 1.63 billion pounds (1.87 billion euros, 2.59 billion dollars) and pointed to further job cuts.(AFP/File/Odd Andersen)" border="0" /></a>AFP - British pharmaceuticals giant GlaxoSmithKline on Thursday announced a 66-percent jump in fourth quarter net profit and pointed to further job cuts as it looks to slash costs amid increased competition.</p><br clear="all"/> <p><a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/afp/20100204/bs_afp/britainpharmacompanyearningsgsk"><img src="http://d.yimg.com/a/p/afp/20100204/capt.photo_1264907862220-1-0.jpg?x=130&y=90&q=85&sig=UgDjgD1U9zLq8dsgulF_4Q--" align="left" height="90" width="130" alt="photo" title="British pharmaceuticals giant GlaxoSmithKline on Thursday announced a 66-percent jump in fourth quarter net profit to 1.63 billion pounds (1.87 billion euros, 2.59 billion dollars) and pointed to further job cuts.(AFP/File/Odd Andersen)" border="0"/></a></p><br clear="all"/> (AFP) http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20100204/ap_on_bi_ge/ny_drugmaker_trade_theft ap/20100204/ny_drugmaker_trade_theft AP business Thu, 04 Feb 2010 01:00:27 GMT AP - A fired Bristol-Myers-Squibb Co. employee stole trade secrets from the drugmaker in a plot to launch his own pharmaceutical business in his native India, a federal prosecutor said Wednesday. http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20100203/ap_on_bi_ge/us_ironwood_pharmaceuticals_ipo_debut ap/20100203/us_ironwood_pharmaceuticals_ipo_debut AP business Wed, 03 Feb 2010 18:53:10 GMT AP - Shares of Ironwood Pharmaceuticals Inc. are up in their IPO debut after the drug developer's offering priced below expectations. http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20100203/ap_on_bi_ge/us_poniard_pharmaceuticals_layoffs ap/20100203/us_poniard_pharmaceuticals_layoffs AP business Wed, 03 Feb 2010 18:25:59 GMT AP - Poniard Pharmaceuticals said Wednesday it will lay off more than half its work force and replace CEO Jerry McMahon. http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20100203/ap_on_bi_ge/us_keryx_perifosine ap/20100203/us_keryx_perifosine AP business Wed, 03 Feb 2010 17:22:15 GMT AP - Keryx Biopharmaceuticals Inc. said Wednesday it reached an agreement with regulators on the design of a late-stage study of its cancer drug candidate perifosine. http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20100203/ap_on_bi_ge/us_vertex_pharmaceuticals_study ap/20100203/us_vertex_pharmaceuticals_study AP business Wed, 03 Feb 2010 16:32:53 GMT AP - Vertex Pharmaceuticals Inc. said Wednesday its experimental cystic fibrosis drug VX-809 met key safety and tolerability goals in a midstage study. http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20100203/ap_on_bi_ge/us_auxilium_pharma_xiaflex ap/20100203/us_auxilium_pharma_xiaflex AP business Wed, 03 Feb 2010 14:44:10 GMT AP - Auxilium Pharmaceuticals said it has received marketing approval for a drug to treat a condition that constricts the fingers and causes them to bend inward. http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/afp/20100203/ts_alt_afp/uscompanypharmaearningspfizer afp/20100203/uscompanypharmaearningspfizer AFP us Wed, 03 Feb 2010 13:20:20 GMT <p><a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/afp/20100203/ts_alt_afp/uscompanypharmaearningspfizer"><img src="http://d.yimg.com/a/p/afp/20100203/capt.photo_1265200450813-2-0.jpg?x=92&y=130&q=85&sig=3bJ6qu7dX6WAqDqTcelxPA--" align="left" height="130" width="92" alt="File photo of Viagra pills. Pharmaceutical giant Pfizer said fourth-quarter net income nearly tripled from a year ago to 767 million dollars, after acquiring rival Wyeth.(AFP/HO/File)" border="0" /></a>AFP - Pharmaceutical giant Pfizer said Wednesday fourth-quarter net income nearly tripled from a year ago to 767 million dollars, boosted by the acquisition of rival drugmaker Wyeth.</p><br clear="all"/> <p><a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/afp/20100203/ts_alt_afp/uscompanypharmaearningspfizer"><img src="http://d.yimg.com/a/p/afp/20100203/capt.photo_1265200450813-2-0.jpg?x=92&y=130&q=85&sig=3bJ6qu7dX6WAqDqTcelxPA--" align="left" height="130" width="92" alt="photo" title="File photo of Viagra pills. Pharmaceutical giant Pfizer said fourth-quarter net income nearly tripled from a year ago to 767 million dollars, after acquiring rival Wyeth.(AFP/HO/File)" border="0"/></a></p><br clear="all"/> (AFP)